POLVERE, JACOPO
 Distribuzione geografica
Continente #
EU - Europa 401
NA - Nord America 154
AS - Asia 31
AF - Africa 5
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 594
Nazione #
US - Stati Uniti d'America 154
IE - Irlanda 140
IT - Italia 138
SE - Svezia 28
FI - Finlandia 27
FR - Francia 21
CN - Cina 17
DE - Germania 16
GB - Regno Unito 12
ES - Italia 6
SG - Singapore 6
ZA - Sudafrica 5
NL - Olanda 4
PL - Polonia 3
IR - Iran 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BO - Bolivia 1
CH - Svizzera 1
EC - Ecuador 1
EU - Europa 1
GR - Grecia 1
HK - Hong Kong 1
IN - India 1
MY - Malesia 1
NO - Norvegia 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
TH - Thailandia 1
Totale 594
Città #
Dublin 139
Siena 35
Ashburn 32
Chandler 30
Florence 29
Helsinki 26
New York 26
Shanghai 13
Princeton 11
Rome 8
Bacoli 6
Fremont 6
Málaga 6
Singapore 6
Baronissi 5
Manchester 5
Washington 5
Lanciano 4
Vanderbijlpark 4
Fairfield 3
Gdynia 3
Naples 3
Salerno 3
Amsterdam 2
Bonn 2
London 2
Messina 2
Milan 2
Nuremberg 2
Rogliano 2
Rosignano Marittimo 2
Southend 2
Trevi 2
Triggiano 2
Woodbridge 2
Athens 1
Beijing 1
Bern 1
Boardman 1
Bologna 1
Central 1
Chiswick 1
Colle di Val d'Elsa 1
Frankfurt am Main 1
Groningen 1
Houston 1
Islamabad 1
Johannesburg 1
Lappeenranta 1
Lisbon 1
Los Angeles 1
Mumbai 1
Oslo 1
Quito 1
Sacramento 1
San Francisco 1
San Miniato Basso 1
Sesto Fiorentino 1
Shenzhen 1
Sucre 1
The Hague 1
Tirana 1
Verona 1
Zanjan 1
Totale 461
Nome #
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines. 76
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 72
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 68
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 58
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 57
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 50
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 50
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine 41
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 33
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 28
Characterization of the humoral and B-cell spike-specific immune response after mRNA SARS-CoV-2 vaccination in healthy and fragile subjects 25
Third Sars-CoV-2 vaccine dose: B cell and antibody responses following heterologous and homologous vaccination strategies. 24
Persistence of spike-specific memory B cells and antibodies nine months after two doses of BNT162b2 mRNA vaccine. 21
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 20
Longitudinal profiling of spike-specific antibody and B cell responses following mRNA-1273 SARS-CoV-2 vaccination in hematopoietic cell transplantation recipients 19
Totale 642
Categoria #
all - tutte 3.320
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.320


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202260 0 0 0 0 0 0 0 0 13 3 21 23
2022/2023242 14 23 37 16 15 26 14 22 12 11 43 9
2023/2024340 8 4 41 39 23 88 94 22 12 9 0 0
Totale 642